SCTXScribe Therapeutics Inc. Common Stock
34.13USD+9.92%Mkt Cap: 643.84M $P/E: —3d ago
Scribe Therapeutics Inc. operates as a clinical-stage biotechnology company, focuses on research and developing genetic medicines using CRISPR-based tools to address the root cause of diseases, with a primary focus on ca…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap643.84M $
Enterprise Value197.99M $
Revenue (TTM)36.28M $
Gross Profit-19.83M $
Net Income (TTM)-21.81M $
Revenue/Share14.87 USD
Last Price34.13 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees89
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-9.53
PEG—
EV/EBITDA-6.61
EV/Revenue5.46
P/S14.64
P/B-0.51
EPS (TTM)-2.19
EPS (Forward)-3.44
52W Range
17.3086% of range36.89
52W High36.89 USD
52W Low17.30 USD
Profitability
Gross Margin-54.65%
Oper. Margin-556.52%
EBITDA Margin-82.62%
Profit Margin-42.62%
ROE15.21%
ROA-27.88%
Growth
Revenue Growth-87.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-45.21M $
CapEx (TTM)1.27M $
FCF Margin—
FCF Yield—
Net Debt-3.40M $
Net Debt/EBITDA0.11
Balance Sheet
Debt/Equity-0.29
Current Ratio0.66
Quick Ratio0.64
Book Value/Sh-64.3110 USD
Cash/Share20.15 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)49.00 USD
Upside (mean)+43.6%
Target Range37.00 USD – 60.00 USD
$37.00+43.6% to mean$60.00
# Analysts3
Ownership
Shares Out.18.86M
Float892.58K
Insiders11.53%
Institutions53.18%
Short Interest
Short Ratio0.7d
Short % Out.1.39%
Shares Short263.07K
Technical
SMA 5023.05 (+48.0%)
SMA 20023.05 (+48.0%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)234.03K
Avg Vol (10d)209.48K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—